Impact of naproxen sodium (Nalgesin® forte) treatment on the performance of daily activities in patients with low back pain or osteoarthritis in regular clinical practice (QLIFE)

26/11/2025
26/11/2025
EU PAS number:
EUPAS1000000831
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

NIS_QLIFE_protocol_summary_2025-07-24.pdf

English (244.7 KB - PDF) View document
Study results
Study report
Study report

NIS_Qlife_summary_final_report_0511202.pdf

English (305.38 KB - PDF) View document
Other information